EATG » Hepatitis

Hepatitis

Vir Biotechnology and Alnylam Pharmaceuticals initiate Phase 1/2 study of VIR-2218

-- Novel investigational RNAi therapeutic for the treatment of chronic hepatitis B virus (HBV) infection -- Subject dosing commenced SAN FRANCISCO, Calif. and CAMBRIDGE, Mass. – November 26, 2018 -…

Countries of eastern Europe and central Asia improve access to HIV, TB and viral hepatitis diagnostic technologies and medicines

In 2017, 130 000 people acquired HIV in countries of eastern Europe and central Asia. Since 2010, the number of new infections has increased by 29%, making it the fastest-growing…

Australian experience shows high DAA uptake and rapid fall in rates of HCV viraemia among people who inject drugs

Providing hepatitis C virus (HCV) therapy with direct-acting antivirals (DAAs) to people who inject drugs can achieve rapid reductions in community prevalence of viraemia, according to Australian research published in…

Eliminating Hepatitis: A unique opportunity that shouldn’t be missed

EU policymakers owe it to Europe’s citizens to make hepatitis a thing of the past, argues Tatjana Reic. Hepatitis C (HCV) is an urgent public health problem for the European…

Eastern Europe and Central Asia adopt statement on fighting infectious diseases

MINSK, 22 November (BelTA) – The international statement on expanding access to affordable and quality assured medicines and diagnostics will help coordinate efforts of Eastern Europe and Central Asia (EECA)…

PHE and NHSE launch national drive to trace hepatitis C patients

Public Health England and NHS England are working to find thousands of people living with hep C, offering them new treatments that, in most cases, cure the illness. Public Health…

Belarus to increase purchase of hepatitis C drugs twofold

Belarus will increase the purchase of modern medications to treat hepatitis C twofold, Belarus' Healthcare Minister Valery Malashko told reporters, BelTA has learned. “In 2017 alone, we used the latest…

US: Targeted hepatitis C testing misses substantial number of cases in correctional setting

Researchers recommend routine testing for all incarcerated individuals upon arrival BOSTON— Results from a new study led by Boston Medical Center (BMC) found routine Hepatitis C testing identified a significant…

Screening for hepatitis B and hepatitis C: benefit unclear due to a lack of suitable studies

Risk-group screening for hepatitis C requires thorough accompanying evaluation Hepatitis B and hepatitis C are viral infections, which are mostly transmitted by blood. Often unnoticed, they can become chronic, causing…

New research aims to help improve uptake of hepatitis C testing

New research published in Scientific Reports shows persisting fears about HIV infection may impact testing uptake for the Hepatitis C Virus (HCV). HCV infects the liver. If left untreated, it can cause…